Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GREENSPAN, Susan L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

Approach to the Prostate Cancer Patient with Bone DiseaseGREENSPAN, Susan L.The Journal of clinical endocrinology and metabolism. 2008, Vol 93, Num 1, pp 2-7, issn 0021-972X, 6 p.Article

The effect of androgen deprivation therapy on periodontal disease in men with prostate cancerFAMILI, Pouran; CAULEY, Jane A; GREENSPAN, Susan L et al.The Journal of urology. 2007, Vol 177, Num 3, pp 921-924, issn 0022-5347, 4 p.Article

The management of osteoporosis following hip fracture: Have we improved our care?BAHL, Sachin; COATES, Penelope S; GREENSPAN, Susan L et al.Osteoporosis international. 2003, Vol 14, Num 11, pp 884-888, issn 0937-941X, 5 p.Article

Quality of life in prostate cancer patients taking androgen deprivation therapyDACAL, Kirsten; SEREIKA, Susan M; GREENSPAN, Susan L et al.Journal of the American Geriatrics Society. 2006, Vol 54, Num 1, pp 85-90, issn 0002-8614, 6 p.Article

Factors Associated with Osteoporosis Screening and Recommendations for Osteoporosis Screening in Older AdultsNAYAK, Smita; ROBERTS, Mark S; GREENSPAN, Susan L et al.Journal of general internal medicine. 2009, Vol 24, Num 5, pp 585-591, issn 0884-8734, 7 p.Article

Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal WomenNAYAK, Smita; ROBERTS, Mark S; GREENSPAN, Susan L et al.Annals of internal medicine. 2011, Vol 155, Num 11, pp 751-761, issn 0003-4819, 11 p.Article

Vignettes in osteoporosis: A road map to successful therapeuticsROSEN, Clifford J; BLACK, Dennis M; GREENSPAN, Susan L et al.Journal of bone and mineral research (Print). 2004, Vol 19, Num 1, pp 3-10, issn 0884-0431, 8 p.Article

Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: A randomized controlled trialGREENSPAN, Susan L; RESNICK, Neil M; PARKER, Robert A et al.JAMA, the journal of the American Medical Association. 2003, Vol 289, Num 19, pp 2525-2533, issn 0098-7484, 9 p.Article

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy : A three-year, double-blind, placebo- controlled, randomized clinical trialGREENSPAN, Susan L; RESNICK, Neil M; PARKER, Robert A et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 5, pp 2762-2767, issn 0021-972X, 6 p.Article

The effect of hormone replacement on physical performance in community-dwelling elderly women : Women's healthGREENSPAN, Susan L; RESNICK, Neil M; PARKER, Robert A et al.The American journal of medicine. 2005, Vol 118, Num 11, pp 1232-1239, issn 0002-9343, 8 p.Article

Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly womenGREENSPAN, Susan L; ROSEN, Harold N; PARKER, Robert A et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 10, pp 3537-3540, issn 0021-972XArticle

Skeletal integrity in patients with nail patella syndromeTOWERS, Adele L; CLAY, Cheryl A; SEREIKA, Susan M et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 4, pp 1961-1965, issn 0021-972X, 5 p.Article

Prevention of bone loss in survivors of breast cancer : A randomized, double-blind, placebo-controlled clinical trialGREENSPAN, Susan L; BHATTACHARYA, Rajib K; SEREIKA, Susan M et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 1, pp 131-136, issn 0021-972X, 6 p.Article

Associations Between Bone Mineral Density, Grip Strength, and Lead Body Burden in Older MenKHALIL, Naila; FAULKNER, Kimberly A; GREENSPAN, Susan L et al.Journal of the American Geriatrics Society. 2014, Vol 62, Num 1, pp 141-146, issn 0002-8614, 6 p.Article

Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry : A 3-year, double-blind, placebo-controlled clinical trialGREENSPAN, Susan L; BECK, Thomas J; RESNICK, Neil M et al.Journal of bone and mineral research (Print). 2005, Vol 20, Num 9, pp 1525-1532, issn 0884-0431, 8 p.Article

Ultraviolet radiation and vitamine D : A historical perspectiveRAJAKUMAR, Kumaravel; GREENSPAN, Susan L; THOMAS, Stephen B et al.American journal of public health (1971). 2007, Vol 97, Num 10, pp 1746-1754, issn 0090-0036, 9 p.Article

Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer : A randomized trialGREENSPAN, Susan L; NELSON, Joel B; TRUMP, Donald L et al.Annals of internal medicine. 2007, Vol 146, Num 6, pp 416-424, issn 0003-4819, 9 p.Article

FRAX or Fiction: Determining Optimal Screening Strategies for Treatment of Osteoporosis in Residents in Long-Term Care FacilitiesGREENSPAN, Susan L; PERERA, Subashan; NACE, David et al.Journal of the American Geriatrics Society. 2012, Vol 60, Num 4, pp 684-690, issn 0002-8614, 7 p.Article

Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohortGUGGINA, Pamela; FLAHIVE, Julie; COOPER, Cyrus et al.Bone (New York, NY). 2012, Vol 51, Num 6, pp 975-980, issn 8756-3282, 6 p.Article

Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)DENNISON, Elaine M; COMPSTON, Juliet E; HOOVEN, Frederick H et al.Bone (New York, NY). 2012, Vol 50, Num 6, pp 1288-1293, issn 8756-3282, 6 p.Article

Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in WomenADACHI, Jonathan D; ADAMI, Silvano; GREENSPAN, Susan L et al.Mayo Clinic proceedings. 2010, Vol 85, Num 9, pp 806-813, issn 0025-6196, 8 p.Article

Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosisANTONIUCCI, Diana M; SELLMEYER, Deborah E; BILEZIKIAN, John P et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 3, pp 942-947, issn 0021-972X, 6 p.Article

One year ofalendronate after one year of parathyroid hormone (1-84) for osteoporosisBLACK, Dennis M; BILEZIKIAN, John P; ENSRUD, Kristine E et al.The New England journal of medicine. 2005, Vol 353, Num 6, pp 555-565, issn 0028-4793, 11 p.Article

Alendronate improves Bone mineral density in elderly women with osteoporosis residing in long-term care facilities: A randomized, double-blind, placebo-controlled trialGREENSPAN, Susan L; SCHNEIDER, Diane L; MCCLUNG, Michael R et al.Annals of internal medicine. 2002, Vol 136, Num 10, pp 742-746, issn 0003-4819Article

A Clinician Performance Initiative to Improve Quality of Care for Patients with OsteoporosisGREENSPAN, Susan L; BILEZIKIAN, John P; WATTS, Nelson B et al.Journal of women's health (Larchmont, N.Y. 2002). 2013, Vol 22, Num 10, pp 853-861, issn 1540-9996, 9 p.Article

  • Page / 3